基本信息
views: 56
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Klings is an Associate Professor of Medicine at Boston University School of Medicine where she directs the Pulmonary Hypertension Center and the Center for Excellence in Sickle Cell Disease. She is an internationally recognized expert in the pulmonary vascular complications of sickle cell disease. She is NIH and industry funded and is currently studying the clinical outcomes of venous thromboembolism in sickle cell disease.
Research Interests
Papers共 179 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
C62. TOP GUN: NOVEL THERAPEUTICS AND OUTCOMES IN PAH (2024)
A93. CRITICAL CARE AND ACUTE CARE MEDICINE: DISPARITIES, QUALITY IMPROVEMENT, AND OUTCOMES (2024)
Joan Barberà,Pavel Jansa,Elizabeth Klings,Arsen Ristić,Anne Keogh, Derek Solum,Youlan Rao,Rob Grover, Isil Saib,Namita Sood
Advances in Therapyno. 3 (2024): 1062-1074
The Lancet Haematologyno. 5 (2024): e345-e357
Shelsey W Johnson, Rui-Sheng Wang, Michael R Winter,Kari R Gillmeyer,Katarina Zeder,Elizabeth S Klings,Ronald H Goldstein,Renda Soylemez Wiener,Bradley A Maron
Diabetes careno. 5 (2024): e42-e43
Rena Zheng, Alexandra Solomon, Madeline DiLorenzo,Iniya Rajendran, Joseph Park,Vrushali Dhongade,Michael A Garcia,Robert T Eberhardt,John Mark Sloan,Janice Weinberg,Elizabeth S Klings
C62. TOP GUN: NOVEL THERAPEUTICS AND OUTCOMES IN PAH (2024)
Robyn T Cohen,Shana A B Burrowes, Christopher J Williams,Caitlin M Neri,Elizabeth S Klings, Kayla C Jones, Allan J Walkey,Mari-Lynn Drainoni
Pediatric blood & cancerno. 9 (2024): e31142-e31142
Lungno. 6 (2023): 565-569
Load More
Author Statistics
#Papers: 179
#Citation: 4306
H-Index: 27
G-Index: 64
Sociability: 7
Diversity: 0
Activity: 2
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn